Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

Recruiting

RitlecitinibCharacterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

Sponsor:

Pfizer

Code:

NCT06531109

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Ritlecitinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-15. This information was provided to ClinicalTrials.gov by Pfizer on 2025-08-11.